Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 255.20
-1.00 (-0.39%)
Aug 11, 2025, 10:57 AM CET
Satixfy Communications Revenue
In the year 2024, Demant had annual revenue of 22.42B DKK with 3.79% growth. Demant had revenue of 11.33B in the half year ending December 31, 2024, with 11.01% growth.
Revenue
22.42B
Revenue Growth
+3.79%
P/S Ratio
2.43
Revenue / Employee
1.05M
Employees
22,639
Market Cap
54.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.42B | 818.00M | 3.79% |
| Dec 31, 2023 | 21.60B | 1.90B | 9.62% |
| Dec 31, 2022 | 19.71B | 1.80B | 10.05% |
| Dec 31, 2021 | 17.91B | 3.44B | 23.75% |
| Dec 31, 2020 | 14.47B | -477.00M | -3.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Coloplast | 27.79B |
| Genmab | 22.30B |
| ALK-Abelló | 5.71B |
| H. Lundbeck | 22.95B |
| Ambu A/S | 5.83B |
| Zealand Pharma | 55.69M |
| Bavarian Nordic | 6.23B |